SAN DIEGO -- Junior Seau, who committed suicide in May, two years after retiring as one of the premier linebackers in NFL history, suffered from the type of chronic brain damage that also has been found in dozens of deceased former players, five brain specialists consulted by the National Institutes of Health concluded.
Seau's ex-wife, Gina, and his oldest son Tyler, 23, told ABC News and ESPN in an exclusive interview they were informed last week that Seau's brain had tested positive for chronic traumatic encephalopathy, a neurodegenerative disease that can lead to dementia, memory loss and depression.
"I think it's important for everyone to know that Junior did indeed suffer from CTE," Gina Seau said. "It's important that we take steps to help these players. We certainly don't want to see anything like this happen again to any of our athletes."
She said the family was told that Seau's disease resulted from "a lot of head-to-head collisions over the course of 20 years of playing in the NFL. And that it gradually, you know, developed the deterioration of his brain and his ability to think logically."
CTE is a progressive disease associated with repeated head trauma. Although long known to occur in boxers, it was not discovered in football players until 2005. Researchers at Boston University recently confirmed 50 cases of CTE in former football players, including 33 who played in the NFL.
Seau shot himself in the heart May 2. His death stunned not only the football world but also his hometown, San Diego, where he played the first 13 years of his 20-year career. Seau led the Chargers to their first and only Super Bowl appearance and became a beloved figure in the community.
Within hours of Seau's death, Tyler Seau said he received calls from researchers hoping to secure his father's brain for study. The family ultimately chose the National Institutes of Health in Washington, D.C., to oversee the research.
Gina Seau said the family chose the NIH because it was a "complete, comprehensive, unbiased scientific institution of the highest level."
The NFL in a statement said the NIH's "finding underscores the recognized need for additional research to accelerate a fuller understanding of CTE."
"The NFL, both directly and in partnership with the NIH, Centers for Disease Control and other leading organizations, is committed to supporting a wide range of independent medical and scientific research that will both address CTE and promote the long-term health and safety of athletes at all levels. The NFL clubs have already committed a $30 million research grant to the NIH, and we look forward to making decisions soon with the NFL Players Association on the investment of $100 million for medical research that is committed in the Collective Bargaining Agreement. We have work to do, and we're doing it," the NFL said.
Dr. Russell Lonser, the former chief of surgical neurology at the NIH, helped coordinate the study. In an interview, Dr. Lonser, who was recently named chairman of the department of neurological surgery at Ohio State University, said that because of the publicity surrounding the case, the study of Seau's brain was "blinded" to ensure its independence.
Three independent neuropathologists from outside the NIH were given unidentified tissue from three different brains; one belonged to Seau, another to a person who had suffered from Alzheimer's disease, and a third from a person with no history of traumatic brain injury or neurodegenerative disease.
Dr. Lonser said the three experts independently arrived at the same conclusion as two other government researchers: that Seau's brain showed definitive signs of CTE. Those signs included the presence of an abnormal protein called "tau" that forms neurofibrillary tangles, effectively strangling brain cells.
A statement released by the NIH said the tangles were found "within multiple regions of Mr. Seau's brain." In addition, the statement said, a small region of the left frontal lobe showed "evidence of scarring that is consistent with a small, old traumatic brain injury."
Dr. Lonser declined to name the neuropathologists who examined Seau's brain.